Effects of hemolysate concentration, ionic strength and cytochrome b5 concentration on the rate of methemoglobin reduction in hemolysates of human erythrocytes.
An assay for determining the rate of methemoglobin reduction in hemolysates of human erythrocytes has been developed. The rates obtained by this assay, when corrected for dilution, are comparable to those obtained with intact cells. Increased ionic strength inhibits the reaction, whereas EDTA increases the rate of reduction. The rate with NADPH as electron donor is 65-70% of the rate with NADH. Added cytochrome b5 stimulates the reaction. The assay has been used to examine erythrocytes from two methemoglobinemic sisters and their asymptomatic mother. Hemolysates of the two patients have both decreased dichlorophenolindophenol reductase activity and decreased ability to reduce methemoglobin. Hemolysates from the heterozygous mother have intermediate dichlorophenolindophenol reductase activity and intermediate methemoglobin reduction ability. The data presented in this paper indicate that the concentrations of cytochrome b5 and cytochrome b5 reductase determine the rate of methemoglobin reduction in hemolysates.
D042966:Cytochrome-B(5) Reductase / Q000097:blood*; D003580:Cytochromes / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism*; D006461:Hemolysis; D007700:Kinetics; D008706:Methemoglobin / Q000378:metabolism*; D008708:Methemoglobinemia / Q000097:blood; D009243:NAD / Q000097:blood; D009247:NADH, NADPH Oxidoreductases / Q000097:blood*; D009249:NADP / Q000097:blood; D009994:Osmolar Concentration; D010084:Oxidation-Reduction
D003580:Cytochromes; D009243:NAD; D009249:NADP; D008706:Methemoglobin; D009247:NADH, NADPH Oxidoreductases; D042966:Cytochrome-B(5) Reductase